If you are a Gemini Advanced subscriber, you can access Gemini 2.0 Pro through the model-picker menu on both desktop and ...

Vertex' outgoing R&D chief Peter Mueller - who has just announced his retirement - must feel he is leaving the company in fine shape.

Keep your eye on the ball” is a motto for many athletes—and for astronomers trying to find Earth-threatening space rocks ...

Google’s Najeeb Jarrar says that brands that prioritise mindful marketing and champion data privacy will be the ones that ...

With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.

The Summerlin master-planned community offers more than 75 unique floor plans in 15 neighborhoods throughout eight distinct ...

Protest outside Meta’s London offices marks launch of Mad Youth Campaign, an effort by activists to challenge the ways in which corporate power negatively shapes the conditions young people live under ...

ByteDance’s OmniHuman-1 generates lifelike human videos from a single image and audio. Discover its key features and compare it with Sora and Veo 2.

A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...

Discover Google's latest AI advancements with Gemini 2.0 Flash Thinking and Pro models, enhancing reasoning and performance ...

Pre-earnings options volume in Vertex is normal with calls leading puts 7:4. Implied volatility suggests the market is anticipating a move near ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...